A Computational Framework for the Topological Analysis and Targeted Disruption of Signal Transduction Networks  by Dasika, Madhukar S. et al.
A Computational Framework for the Topological Analysis and Targeted
Disruption of Signal Transduction Networks
Madhukar S. Dasika, Anthony Burgard, and Costas D. Maranas
Department of Chemical Engineering, The Pennsylvania State University, University Park, Pennsylvania 16802
ABSTRACT In this article, optimization-based frameworks are introduced for elucidating the input-output structure of signaling
networks and for pinpointing targeted disruptions leading to the silencing of undesirable outputs in therapeutic interventions.
The frameworks are demonstrated on a large-scale reconstruction of a signaling network composed of nine signaling pathways
implicated in prostate cancer. The Min-Input framework is used to exhaustively identify all input-output connections implied by
the signaling network structure. Results reveal that there exist two distinct types of outputs in the signaling network that either
can be elicited by many different input combinations or are highly speciﬁc requiring dedicated inputs. The Min-Interference
framework is next used to precisely pinpoint key disruptions that negate undesirable outputs while leaving unaffected necessary
ones. In addition to identifying disruptions of terminal steps, we also identify complex disruption combinations in upstream
pathways that indirectly negate the targeted output by propagating their action through the signaling cascades. By comparing
the obtained disruption targets with lists of drug molecules we ﬁnd that many of these targets can be acted upon by existing drug
compounds, whereas the remaining ones point at so-far unexplored targets. Overall the proposed computational frameworks
can help elucidate input/output relationships of signaling networks and help to guide the systematic design of interference
strategies.
INTRODUCTION
Recent years have witnessed an increasing interest in the
study of cell signaling cascades as the critical role of these
networks in various cellular events is becoming better
understood. A typical signaling pathway involves the capture
of extracellular signals and the subsequent transduction
inward to control target proteins or gene expression (1). For
example, in response to stimulation by speciﬁc ligands, the
receptor tyrosine kinases regulate a great diversity of cellular
processes including cell migration, cell proliferation, and
differentiation (2). Similarly, the vascular endothelial growth
factor (VEGF) family of ligands and receptors has been im-
plicated in vascular development and neovascularization (3).
The connectivity of signaling networks is being unraveled at
an ever increasing pace (4–6). This brings to the forefront the
challenge of devising novel strategies for systematically
deducing the stimuli capable of eliciting a particular cellular
response and deciphering how to ‘‘shape’’ their connectivity
to negate undesirable outputs (e.g., P70S6K, a suppressor of
apoptosis) without affecting necessary ones (e.g., glycogen
synthesis) (7,8). This article introduces an integrated com-
putational base for addressing these questions for large-scale
signaling network reconstructions using a stoichiometric
description of molecular transformations and a Boolean
description of activations and inhibitions. The lack of any
kinetic information in the adopted modeling descriptions
implies that no dynamic effects in signal propagation are
captured (e.g., signal timing). Additional complications may
include cell-type dependent inhibition or activation, com-
partmentalization and the impact of spatial organization in
general. Therefore, only connectivity-encoded insight can be
elucidated, implying that further detailed kinetic-based
analysis may be needed to fully recapitulate the underlying
input-output structures and/or interventions.
Genomic advances have provided a major impetus to the
large-scale reconstruction of signaling pathways. Numerous
databases are under development to catalog the astounding
complexity associated with cell signaling networks. For ex-
ample, the Reaction entries in the TRANSPATH database
(9,10) allow the query of the upstream and downstream
connectivity of signaling molecules by providing direction-
ality and stoichiometry information for each interaction. The
integration of TRANSPATH with TRANSFAC (11), a data-
base for transcription factors and their DNA binding sites,
provides the means to obtain complete signaling pathways
from the binding of a ligand to the set of affected genes. The
Alliance for Cellular Signaling (12), has brought forward the
Molecule Pages database (13), which contains extensive
information about more than 3,700 signaling proteins present
in cellular signaling. Each entry, contributed by invited ex-
perts and peer-reviewed, contains information on a protein’s
known states including a list of sequence, kinetic, and ther-
modynamic parameters when available. Both the Alliance
for Cellular Signaling and TRANSPATH programs have the
ultimate goal of providing the kinetic parameters necessary
for the quantitative simulation of large signaling networks to
aid in drug target discovery and evaluation. The Biomolecular
Interaction Network Database (14,15) and the Database of
Interacting Proteins (16) store protein-protein interaction data
representing ;15,000 and 11,000 interactions, respectively.
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Finally, the PANTHER (17) database is a repository for cell
signaling pathways and includes interactive resources for
associating protein families with their biological pathways,
as well as new tools for analyzing gene expression data in
relation to molecular functions, biological processes, and
pathways.
Signaling cascades were originally thought to function via
linear routes where a single extracellular signal (i.e., input)
would trigger a linear chain of reactions resulting in a single
well-deﬁned response (i.e., output) (18). However nowa-
days, it is unanimously accepted that biological responses to
external stimuli are much more complicated and the result of
multiple interacting pathways containing many common
molecules (19–22). Many researchers have attempted to
model and simulate the signaling cascades. These include
modeling studies conducted on localized aspects of the cell
signaling process such as the kinetic and spatial analysis of
cell surface receptor mechanisms (23,24), analyses of the
cascades (25,26), analyses of speciﬁc signaling system
modules (27–30), and analyses of timing- dependent recep-
tor speciﬁcities (31). Speciﬁcally, the Database of Quanti-
tative Cellular Signaling provides a repository of modules
(i.e.,,100 reactions) of signaling pathways containing;1/3
of all published kinetic models of signaling pathways (4). To
date, the most detailed modular-type kinetic analysis
involves the construction of a dynamic model of the MAP
kinase cascade activated by epidermal growth factor (EGF)
receptors (32). This model describes the temporal concen-
tration proﬁles of 94 compounds participating in 62 bio-
chemical transformations triggered by EGF stimulation.
Though impressive, a total of 94 compounds is still only a
small fraction of the 2,503 unique chemical species that have
so far been identiﬁed in humans and cataloged in the
TRANSPATH database (9).
Faced with the paucity of accurate and comprehensive
kinetic data, the key question is whether only the topology
and connectivity alone of signaling networks can provide
information to qualitatively predict some of their allowable
states and responses to stimuli. Interestingly, a number of
studies have shown that signaling networks are quite robust
with respect to variations in kinetic parameters, implying that
their key properties may be largely established by their
network architecture. For example, it has recently been
deduced that the core topology of the interactions of the
Drosophila segment polarity genes in differentiation was
sufﬁcient to deduce the properties expected of a develop-
mental module, irrespective of the exact values of the kinetic
parameters or initial conditions (33–35). Furthermore, a
Boolean model of the segment polarity genes based solely on
binary (0–1) representation of transcript and protein levels
was able to reproduce wild-type gene expression experi-
ments along with expression patterns in various mutants and
overexpression experiments (36). In their study of the EGF
signaling system, Schoeberl et al. (32) concluded that the
EGF-induced responses were remarkably stable over a 100-
fold range of ligand concentrations and were unexpectedly
robust to variations in kinetic parameters and initial condi-
tions. In Escherichia coli chemotaxis, the precision of
tumbling frequency adaptation to external stimulant concen-
trations was found to be quite robust despite substantial
variations in network-protein concentrations. (37,38). The
local responses at each level of a signaling cascade have been
shown to amplify, enabling the total response of the cascade
to operate almost as a switch where the target is activated in
response to a given signal (39). Lastly, it has been found that
engineering the topology of signaling networks alone was
able to change response speciﬁcity in Saccharomyces
cerevisiae resulting in cells eliciting an osmolarity response
to a mating signal (40,41).
Therefore, the newly available large-scale signaling
network reconstructions motivate the need to explore compu-
tationally their signal transfer properties and possible re-
designs. Speciﬁcally, the question of how many signaling
inputs are required to elicit a particular cellular response has
already drawn attention (5). The examination of alternative
sets of input signaling molecules that are capable of trig-
gering the same response provides insight into the degen-
eracy built into signaling networks and their organizational
principles. In another context, degeneracy has been shown to
play an important role in the robust behavior exhibited by the
cellular, metabolic, and regulatory networks (42). To address
this need, we put forward an optimization based framework,
(Min-Input problem) that exhaustively identiﬁes all sets
of input signaling molecules that are required to elicit a
particular cellular outcome (see Fig. 1 a) in the context of
large-scale signaling networks.
FIGURE 1 Pictorial representation of the problems and solution strategies
proposed in this article. The Min-Input framework (a) identiﬁes the minimal
sets of input signaling molecules that are capable of eliciting a particular
cellular outcome. The Min-Interference framework (b) identiﬁes the mini-
mal combinations of disruptions to prevent an undesirable outcome while
preserving a set of the desired outputs.
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Dysfunctions in the signaling architecture have often been
implicated in a wide range of diseases. For example, dereg-
ulation of Ets transcription factors results in formation of
malignant cells leading to tumorous growth (43). Similarly,
dysfunctions in the activity of the receptor tyrosine kinases
and corresponding signaling pathways have been linked to
diabetes and cancer (2). Several drug development studies
focus on identifying therapeutic agents that are capable of
disrupting a targeted set of chemical transformations within
the signaling pathways through competitive binding. Unfor-
tunately, due to the complexity of the networks, the unin-
tended consequences of these disruptions to desired outputs
are not systematically explored. However, by considering sys-
temwide reconstructions of signaling pathways, the far reaching
effects of these disruptions could be traced over the entire
signaling cascades. To this end, we introduce the optimiza-
tion-based framework (i.e., Min-Interference problem) that
pinpoints the minimal combinations of chemical transfor-
mations that need to be disrupted to prevent an undesirable
cellular response while preserving desired ones (see Fig. 1 b).
The proposed computational base is demonstrated on nine
human signaling pathways that have been implicated in the
growth and development of prostate cancer (Table 1). This
network, extracted from the PANTHER (17) database of
signaling networks, involves 322 chemical transformations
and 526 distinct chemical entities. A description of the
procedure used to download and process all pathway data is
provided in the next section. Subsequently, the adopted
mathematical description of the signaling network is high-
lighted followed by a detailed presentation of the computa-
tional frameworks for the Min-Input and Min-Interference
problems including results and some comparisons to data
from open literature.
MATHEMATICAL MODELING
Pathway data
Table 1 lists all nine pathways considered in this study to
highlight the proposed computational frameworks. We used
implication to prostate cancer as a selection criterion.
Prostate cancer is the second highest cause of cancer related
deaths in the United States and many research efforts are
directed toward elucidating the pathways whose upregula-
tion or downregulation promotes malignant behavior (44).
Many of the chemical transformations in the signaling
pathways are either activated or repressed by chemical
entities present in the system. For example, protein tyrosine
hydroxylase activates the transformation of tyrosine to 3,4-
dihydroxyphenylalanine in the adrenaline synthesis pathway.
Similarly, the presence of Akt suppresses the recruitment of
capsase 9 in the angiogenesis pathway, which plays an
important role in blood vessel formation. Therefore, in
addition to stoichiometry, representation of the network
topology requires identiﬁcation of the activation and inhi-
bition agents and interactions. As explained before, the
pathways investigated in this work were downloaded from
the PANTHER database of signaling networks in SBML for-
mat (45). PANTHER is publicly available without restriction
at http://panther.appliedbiosystems.com. We developed cus-
tomized scripts using Perl (46) to mine the chemical trans-
formations, chemical entities, and activating and inhibiting
interactions and convert them into a format readable by the
GAMS (47) optimization environment. The ﬁnal data set
consists of 322 chemical transformations, 526 chemical en-
tities, 198 activation interactions, and 38 inhibition interac-
tions and it is available as supplementary material.
Basic deﬁnitions
Signaling pathways are represented using a stoichiometric
formalism that has been extensively used to model metabolic
networks (48). The key features of this formalism include
explicit accounting of every chemical transformation such as
binding, dimerization, and phosphorylation, and balancing
around every chemical entity. The component balances
governing a signal transduction network involving N ¼
f1, . . . , ng chemical transformations and M ¼ f1, . . . , mg
chemical entities are as follows:
dCi
dt
¼ +
n
j¼1
Sij rj; "i 2 M: (1)
HereCi denotes the concentration of chemical entity i, Sij is the
stoichiometric coefﬁcient of chemical entity i in chemical
transformation j, and rj is the corresponding ﬂux of transfor-
mation j. The rate-limiting steps in cell signaling processes are
typically either receptor internalization or transcriptional reg-
ulation, bothwith time constants on the order of 102 s. The time
constants for the signaling transformations are on the order of
1–10 s allowing a steady-state assumption to be invoked:
+
n
j¼1
Sij rj ¼ 0; "i 2 M: (2)
Our reaction set considers the transcription factors as the
endpoints and do not take into account the subsequent tran-
scriptional regulation of targeted genes
TABLE 1 Signaling pathways investigated in this study
Pathways involved in prostate cancer cells
1. Angiogenesis
2. Apoptosis_signaling_pathway
3. Cell_cycle
4. EGF_receptor_signaling_pathway
5. Hypoxia_response_via_HIF_activation
6. Insulin_IGF_pathway_MAP_kinase_cascade
7. JAK_STAT_signaling_pathway
8. P53 pathway
9. PI3_kinase pathway
The pathways were obtained from the PANTHER database.
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Modeling activating interactions
Activators are chemical entities that act as catalysts and
enable speciﬁc chemical transformations. In such situations,
the corresponding chemical transformation can take place
only if the requisite activator is present subject to the
availability of the reactants. The following simple example
explains how we model activation using only a stoichiomet-
ric description of chemical transformations.
Consider the chemical transformation A/B, which is
activated by a chemical entity X (Fig. 2 a). Even though the
presence of X is necessary to carry out the transformation,
there is no net change in the amount of X and thus an un-
ambiguous stoichiometric coefﬁcient value cannot be as-
signed to it. To overcome this dilemma, we duplicate the X
chemical entity into XR and XP depending on whether X is a
‘‘reactant’’ or ‘‘product’’ species with respect to the reaction
at hand (i.e., A/B). Accordingly, activation by X is mod-
eled using the following simple reaction steps (see Fig. 2 b):
ðproduction or input of XÞ/XR
A1XR/B1XP
X
R/XP
X
P/ðconsumption or output of XÞ:
The ﬁrst reaction step ensures that all X present as input or
generated through chemical transformations is denoted as
XR. This deﬁnes a pool XR of ‘‘reactant’’ X, which, only if
available, could be used in the second step to carry out the
A/B transformation, which also converts XR to XP. The
third step allows for X to directly ﬂow from its ‘‘reactant’’ XR
to its ‘‘product’’ XP form without having to necessarily
participate in reaction A/B. Finally, the last step enables X
to be consumed or become an output to prevent accumula-
tion. This representation of activation enables a nonzero ﬂux
through the reaction A/B if and only if activator X is
available in the system. All the transformations modeling
activating interactions are irreversible. It is important to note
that based on the above deﬁnitions, the extent of the A/B
reaction is constrained by the amount of XR. However, this is
not a problem because we are examining network properties
of signaling pathways that are dependent upon the presence
or absence of ﬂow rather than exact values.
This formalism for modeling activation within a stoichi-
ometric framework can be generalized for any chemical
transformation. Based on the above deﬁnitions and by du-
plicating all activators into corresponding ‘‘reactant’’ and
‘‘product’’ pools, any reaction requiring activation by a sin-
gle or multiple species can be expressed as the combination
of the elementary steps described above.
Modeling inhibiting interactions
Inhibition interactions are ubiquitous in signaling pathways.
Despite the conceptual similarity of inhibitions to activations,
we did not ﬁnd an equivalent way to express them in a purely
stoichiometric fashion. Therefore,we had tomake use of binary
variables Yj (i.e., acting as on/off switches) to model inhibited
chemical transformations depending on the presence or absence
of the inhibitor. The binary variable Yj is deﬁned as follows:
Yj ¼ 1; implies reaction j is active0; implies reaction j is disrupted

The above condition for setting the values of Yj along with
the constraint 0# rj#UYj ensure that the ﬂux rj is set to zero
if Yj¼ 0 and it can assume any value between 0 andU if Yj¼ 1.
The magnitude of parameter Uwas ﬁxed at 103 for all the
computational studies conducted in this work. We also deﬁne
the set Mjihb as the set of inhibitors for transformation j.
The presence or absence of an inhibiting chemical species
i 2 Mjihb is determined by examining if at least one chemical
transformation leads to production of inhibitor i or i is sup-
plied as an input. The amount of i produced by or supplied as
input to the system is given by the term +j 0 2Ji
P
S
ij
0 r
j
0 , where
JiP is the set of chemical transformations (including input
reactions) leading to the production of i.
If +
j
0 S
ij
0 r
j
0.0;then inhibitor i is present and the ﬂux
through transformation j is set to zero. This condition is de-
scribed mathematically as the following set of constraints:
Yj#1 ð+
j9
Sij0 rj0 Þ=L; " j 2 N; i 2 Mjihb; j0 2 J iP
Parameter L is chosen so that the term ð+
j
0 S
ij
0  r
j
0 Þ=L is
always ,1. Given the scale of ﬂows in the network, a value
of L ¼ 106 was sufﬁcient for all computational studies
presented in this study. Therefore, through the application of
duplicated chemical species and binary variables, both
activating and inhibiting interactions are properly described.
Identifying and eliminating loops
Signaling networks are often characterized by the existence
of cycles (i.e., loops) in the ﬂow of information. Speciﬁcally,
FIGURE 2 Modeling activating interactions. Shown in a is the chemical
transformation A/B, which is activated by the chemical entity X.
Activation interaction is indicated by an arrow with a dot at its tail. Shown
in b is the pathway resulting after accounting for activation. The activator
X is duplicated as XR and XP. The new transformations introduced are
represented by dotted arrows. In both panels, the dashed arrows account for
the production and transfer of chemical entities.
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a chemical entity i participates in a loop if there exists a ﬁnite
number of chemical transformations that starting from i can
lead back to the formation of the chemical entity i. Cyclic
motifs or loops lead to the formation of disjoint subnetworks
that can have nonzero ﬂows, at steady state, even in the
absence of required input signaling molecules. A practical
manifestation of this is the incomplete identiﬁcation of all
inputs needed for an output. To illustrate this point, consider
the pathway posed by Papin and Palsson (5) for the gener-
ation of the STAT1 homodimer output from the input sig-
naling molecules, rIFNg, JAK2, IFNg, STAT1, and ATP
(Fig. 3 a). Also shown in Fig. 3 a is one possible ﬂux
distribution that recruits input signaling molecules ATP and
STAT1 alone to produce STAT1 homodimer. Hence, the
presence of the loop at interferon-g JAK2 receptor ligand
complex allows the assignment of nonzero ﬂows toward the
production of STAT1 homodimer in the presence of ATP
and STAT1 even if the required inputs rIFNg, JAK2, and
IFNg are absent. To overcome this problem, we have
developed a loop-breaking procedure that ﬁrst identiﬁes all
linearly independent loops and subsequently breaks them
by duplicating chemical species forming the junction points
of the identiﬁed loops. Brieﬂy, the procedure involves an
iterative algorithm that selects each chemical entity and sub-
sequently traces the path from the selected chemical entity to
the input entities. If the same chemical entity is encountered
again in the traced path, then a loop exists at the speciﬁc
chemical entity. The chemical entity is subsequently dupli-
cated to eliminate the loop and the algorithm is applied to the
new network to ﬁnd additional loops. This procedure is
repeated until no loops are identiﬁed. For example, by ap-
plying the loop-breaking procedure to the example shown in
Fig. 3 a, a topologically equivalent loop-free network is
obtained (see Fig. 3 b). It can be seen from Fig. 3 b that the
network ﬂow balance condition (Eq. 2) now ensures the re-
cruitment of all the ﬁve inputs toward the production of
STAT1 homodimer.
A composite block diagram indicating the important steps
in the network modeling is shown in Fig. 4. The statistics of
the resulting network are summarized in Table 2. As shown
in the table, the curated network involves 1,338 chemical
transformations, of which 249 are inputs and 75 are the out-
puts, and consists of 1,063 chemical entities. This network is
used as the basis for all subsequent computational studies.
COMPUTATIONAL STUDIES
Min-Input problem
The identiﬁcation of all combinations of input signals that
could lead to a desired cellular response represents a signif-
icant challenge for large and highly interconnected signaling
networks. The proposed approach exhaustively identiﬁes the
smallest nondecomposable sets of inputs that could elicit a
particular cellular response (see Fig. 1 a) using an optimi-
zation-based framework. The mathematical description of
FIGURE 3 Application of loop-break-
ing procedure: a shows the pathway for
generating the STAT1 homodimer before
application of loop-breaking procedure.
The pathway is characterized by the
existence of loop at interferon-g-JAK2
receptor ligand complex. The loop is
represented by dotted arrows in a. b
shows that the topologically equivalent
loop-free pathway is obtained by dupli-
cating the complex (represented in red).
The input molecules are shown with
triangles.
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the optimization problem requires the deﬁnition of a number
of sets that identify chemical entities that serve only as inputs
Min or outputs Mout, respectively, in the signaling pathways.
Speciﬁcally, the stoichiometric coefﬁcients Sij for all inputs
must be nonpositive for every chemical transformation j.
Similarly, the stoichiometric coefﬁcients Sij are nonnegative
for all outputs in all chemical transformations j.
Transport reactions provide input and output species with a
way to enter and leave, respectively, the signaling pathways
ensuring balanceability under the quasi steady-state assump-
tion. Transport reactions form sets Nin and Nout, respectively:
Nin ¼ fj 2 Nj j is a source of an inputg
Nout ¼ fj 2 Nj j is a sink for an outputg:
Based on the above variable and set deﬁnitions, the prob-
lem of identifying all minimal inputs capable of eliciting a
desired output i, where i 2 Mout, is posed as the following
mixed-integer linear programming (MILP) problem:
Minimize +
j2Nin
Yj (3)
subject to
+
N
j¼1
Sijrj ¼ 0"i 2 M (4)
r
Ou
i
$1 (5)
Yj#1
ð+
j
0
Sij0rj0 Þ
L
; "j 2 N; i 2 Mjihb; j0 2 J iP (6)
0# rj#UYj "j 2 N (7)
Yj 2 f0; 1g"j 2 N: (8)
The objective function minimizes the number of inputs
required to allow a particular response (output i). Constraint
4 imposes the quasi steady-state condition. Constraint 5
ensures that the ﬂux to the output transformation corre-
sponding to the desired output (i.e., i) is nonzero. Constraint
set 6 accounts for the inhibition interactions. Finally, con-
straint 7 ensures that the reaction ﬂux rj is set to zero if Yj is
equal to zero. Alternatively, if Yj is equal to 1, then rj can
assume any value between zero and U as described pre-
viously. The above formulation is solved sequentially for
every chemical entity that has been characterized to be an
output of the signaling network (i.e., for every i 2 Mout) to
extract the minimal sets of inputs for every output of the
signaling network. Often times several nondecomposable
sets of inputs exist that could elicit a particular cellular
response. Exhaustively identifying all sets of inputs requires
utilizing the above formulation in an iterative procedure
while successively implementing constraints known as
integer cuts. Speciﬁcally, we impose the constraint 9:
+
j2NinjYiterj ¼1
Yj# +
j2Nin jYiterj ¼1
Y iterj  1; (9)
where Yiterj ; j 2 Nin corresponds to the values of binary
variables obtained at a particular iteration. The constraints at
each successive iteration are accumulated to exclude previ-
ously found solutions. If the problem becomes infeasible,
then no other sets of inputs that can elicit the formation of the
desired outcome remain and the procedure terminates.
Convex analysis-based methods such as extreme pathway
(49) and elementary mode (50,51) analysis represent other
alternatives for obtaining an exhaustive identiﬁcation of all
input/output structures. These approaches require the com-
putation of all convex basis vectors that can represent every
possible combination of reactions rates that are feasible to
the network. However, convex analysis-based methods have
been found to have poor scalability when applied to large
networks (52). In contrast, the proposed formulation is based
on linear programming and MILP principles and is scalable
to thousands of chemical transformations. Similar linear
FIGURE 4 Composite block diagram illustrating the important steps in
the network modeling procedure. First, the pathway data from PANTHER
database is downloaded and subsequently curated to convert the data into a
spreadsheet readable format. Next, we identify chemical transformations,
chemical entities, activating, and inhibiting interactions using customized
PERL (46) scripts. Next, the identiﬁed activating and inhibiting interactions
are modeled as described, and ﬁnally the loop-breaking procedure is em-
ployed to represent any loops embedded in the network.
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programming and MILP based procedures have been suc-
cessfully demonstrated on genome-scale metabolic networks
in various microorganisms containing thousands of meta-
bolic reactions (53–56).
In addition to solution tractability to large networks, the
proposed formulation can be readily modiﬁed to address a
number of biologically relevant questions. For example, the
minimal sets of inputs that are required for attaining not just a
single but multiple outputs can be identiﬁed by simply set-
ting the ﬂows through all the desired outputs .1. Similarly,
the formulation can be modiﬁed to conduct an input/output
feasibility analysis as in Pappin and Palsson (5). A feasible
input/output relationship implies that given a set of signaling
inputs, there exists a set of chemical transformations that lead
to the production of the desired output. This is accomplished
by replacing the objective function with Maximize rdesired
and replacing constraint 5 with rIni$1" i 2 MavaIn , where
rdesired represents the ﬂux on the desired output transforma-
tion and the set MavaIn is the set of available inputs.
Computational results
The breadth of questions that can be answered by solving the
Min-Input problem and the biological insights obtained are
highlighted by applying the procedure to the large-scale net-
work model constructed from the pathways characterizing
the growth and development of prostate cancer. Speciﬁcally,
we address the following three key challenges in the context
of the signaling network described in the Table 2:
i. Identify the minimal number of inputs required to elicit
a particular outcome.
ii. Identify the degeneracy of a particular output by ex-
haustively enumerating all possible sets of input signal-
ing molecules that lead to a particular outcome.
iii. Analyze the interconnection between the inferred input/
output structures.
By iteratively solving the Min Input problem once for
each output, we generated the distribution of the minimum
number of inputs required to realize a particular output (see
Fig. 5). As shown in Fig. 5, the minimum number of required
inputs to elicit an output ranges from as low as 1 input to as
high as 15. This is a manifestation of the highly varied to-
pologies of the identiﬁed input/output structures. We observe
single linear paths to highly interconnected cascades (see
Fig. 6) depending on the output. Speciﬁcally, in the case of
apoptosis, a single intracellular input of capsase 3 protein
needs to be provided (see Fig. 6 a). Alternatively, as shown
in Fig. 6 b, the input/output structure characterizing the
formation of protein survivin resembles a simple linear cas-
cade. Finally, we ﬁnd that input/output structure of phos-
phorylation of BAD is much more complex and is formed by
multiple interacting linear cascades (see Fig. 6 c).
Next, the degeneracy of the outputs is examined by
exhaustively identifying all sets of input molecules capable
of triggering the response of a particular outcome. The dis-
tribution of the number of alternative sets of input molecules
capable of eliciting a given response is shown in Fig. 7.
Interestingly, the distribution of output degeneracy is a
convex function with a minimum in the middle and two
maxima at the two extremes. This suggests that the examined
signaling pathways are characterized by the existence of two
distinct sets of outcomes (i.e., outputs) that are either highly
degenerate or highly speciﬁc. Table 3 summarizes the
number of input/output structures identiﬁed for each output
present in our signaling pathways. For example, we ﬁnd that
nine alternative sets of input signaling molecules are capable
of triggering the apoptotic machinery, whereas there is only a
single way of triggering the deregulation of the apoptotic
machinery by enabling the activation of NF-kB. The
presence of alternative strategies to realize an outcome can
be rationalized as an evolutionary adaptation to protect
against failure, thus improving response robustness (42).
Therefore, a high degree of degeneracy for a particular out-
come may allude to the importance of the role played by that
component in the cell.
In the previous paragraph, we examined output degen-
eracy. Next, we quantify input degeneracy by identifying
whether there exist any input signaling molecules that are
highly recruited. The distribution of the number of input/
output structures that require the participation of a particular
input is shown in Fig. 8. It can be seen that the number of
input/output structures that recruit a particular input can be
as low as 1 to as high as 130. This clearly demonstrates that
most inputs are narrowly recruited to trigger only a handful
FIGURE 5 Graph depicts the distribution of minimal number of inputs
required to realize a particular output. The broadness of the distribution
suggests that the input/output structures span a wide spectrum in terms of
their complexity.
TABLE 2 Number of chemical transformations, chemical
entities, input transformations and output transformations
Statistics of the network model
Chemical transformations 1014
Chemical species 1063
Input transformations 249
Output transformations 75
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of outputs, although a few key inputs are implicated in trig-
gering a large number of outputs. Speciﬁcally, 73% of inputs
signaling molecules were found to be narrowly recruited
(i.e., recruited by 10 or less input/output structures), whereas
10% of input signaling molecules were found to be highly
recruited (i.e., recruited by 50 or more input/output struc-
tures). The complete list of highly recruited input signaling
molecules is provided in Table 4. As expected, energy
transfer metabolites such as ATP and GTP and proteins such
as Grb2 and Sos were found to be highly recruited. This is in
agreement with experimental observations that report that
the protein Grb2 is a crucial component linking the receptor
tyrosine kinase pathways (e.g., VEGF, EGF) with down-
stream proteins such as Ras and Sos (57). The identiﬁcation
of highly/narrowly recruited input signaling molecules is
important for developing targeted therapeutic interventions
in signaling pathways. Speciﬁcally, interfering with a highly
recruited signaling molecule is more likely to lead to side
effects by negating many possibly desirable outputs.
In summary, we ﬁnd that the topology of the input/output
structures varies widely from simple linear paths to highly
connected cascades. Output degeneracy tends to be either
very high or very low, whereas input degeneracy is very low
for most inputs and very high for a few key inputs (expo-
nential distribution). Clearly, input and output degeneracy
plays a key role in understanding the organizational princi-
ples of signaling networks and devising therapeutic inter-
ventions by blocking key transformations. In the next section,
we describe how to systematically identify which transfor-
mations to disrupt to deny and/or enable different outcomes.
FIGURE 6 Complexity of input/output structure varies from single linear paths to highly interconnected linear cascades. In a, the input/output structure for
capsase 3 resembles a simple linear path requiring just one input. In b, the input/output structure for survivin represents a linear cascade requiring a minimum of
ﬁve inputs. In c, the input/output structure for BAD is much more complex and has many interacting linear cascades.
FIGURE 7 Graph shows the number alternative input/output structures
realized for each output. The distribution is a convex function with a mini-
mum in the middle and maxima at two extremes, implying the existence of
two distinct set of outcomes (highly degenerate or highly speciﬁc outputs).
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Min-Interference problem
The results for the Min-Input problem indicate that cellular
outputs can be stimulated by several different signaling
molecules hinting at the enormous complexity associated
with disrupting signal transduction. Given a set of input sig-
naling molecules (Min), the Min-Interference problem pin-
points the minimal disruption strategies needed to prevent an
undesirable cellular outcome while preserving the desired
ones (see Fig. 1 b). At the core of the search algorithm is the
bilevel optimization problem depicted pictorially in Fig. 9.
Bilevel programming problems are hierarchical optimization
problems where the constraints of one problem (outer prob-
lem) are deﬁned in part by a second parametric optimization
problem (inner problem). Speciﬁcally, in the case of the Min-
Interference problem, the inner level problem identiﬁes the
worst-case scenario response of the network by maximizing
the ﬂow to the undesirable response. The outer problem then
guarantees that the solution of the inner problem is equal to
zero by systematically disrupting a minimal number of trans-
TABLE 3 Number of alternative input/output structures
identiﬁed for each output
Number of alternative
input/output structures identiﬁed for each output
Mitogenesis_br_
Differentiation_Cytosol
1 ComplexAxinAPCGSK3_
beta__PlasmaMembrane
2
endoG_Intracellular 1 PLD_PlasmaMembrane 2
Anti-apoptosis_Nucleus 1 PLA_sub_2_endsub_
PlasmaMembrane
2
ComplexI_kappa_BNF_
kappa_B_Intracellular
1 Src_PlasmaMembrane 2
a127_degraded_Intracellular 1 PTEN_ 2
ComplexBcl-2Bik_Intracellular 1 ARF_ 2
CSL_Nuclearmembrane 1 Genetranscription_nucleus 2
Dsh_PlasmaMembrane 1 Bid_Mitochondria 3
TCF_Nuclearmembrane 1 ELF2_alpha__Intracellular 3
Grb14_PlasmaMembrane 1 Rac_PlasmaMembrane 3
Pak_PlasmaMembrane 1 IP3_ER 3
Grb2_PlasmaMembrane 1 ADP_Cytosol 3
RasGAP_PlasmaMembrane 1 Pro-apoptotic_Intracellular 4
Tumorsuppression_ 1 Ets_Nuclearmembrane 4
Survival_ 1 Survivin_PlasmaMembrane 4
ADP_cytosol 1 ComplexeNOSCa_
super_21_endsuper_
PlasmaMembrane
4
VHL_cytosol 1 ComplexcPLA_sub_2_
endsubCa_super_21_
endsuper_
PlasmaMembrane
4
a64_degraded_cytosol 1 VRAP_PlasmaMembrane 4
MetabolismGenes_
br_IncreasedGlycolysis_
Nucleus
1 Sck_PlasmaMembrane 4
Increased_br_Angiogenesis_
Nucleus
1 HSP27_PlasmaMembrane 4
Pro-apoptotic_br_genes_
Nucleus
1 Complexc-Junc-Fos_
Nuclearmembrane
5
ADP_Cytoplasm 1 Paxillin_PlasmaMembrane 5
Pi_Cytoplasm 1 Survival_br_Apoptosis_
br_cell_space_
migration_Cytosol
6
ADP_ 1 Gene_space_
transcription_Cytosol
6
2ADP_Cytoplasm 1 PI3,4P2_cytoplasm 8
Pi_nucleus 1 GDP_cytoplasm 8
ComplexGPCRligandGPC
RG_sub__alpha__cytoplasm
1 S6K_cytoplasm 8
Pre-replication_br_Complex
_SPhase
1 Pro-apoptotic_Nucleus 9
Rb_LateG_sub_1_endsub_ 1 ADP_cytoplasm 10
ADP_Mitosis 1 Pi_cytoplasm 10
a102_degraded_Mitosis 1 GSK3_cytoplasm 10
a_300_ 1 Caspase-9_cytoplasm 10
a87_degraded_Cytosol 2 BAD_cytoplasm 10
Transcription_br_
cellcycleprogression_
Cytosol
2 NOS_cytoplasm 10
STAT3_Nuclearmembrane 2 ComplexFOXO
14-3-3_cytoplasm
10
STAT1_Nuclearmembrane 2 Cyclind_nucleus 10
GADD45_nucleus 10
scl-1_nucleus 10
IGFBP1_nucleus 10
FIGURE 8 Graph depicts the number of times a particular input is recruited
by an input/output structure. Highly recruited inputs include common cur-
rency such as ATP GTP along proteins such as Grb2 and Sos.
TABLE 4 Highly recruited input signaling molecules
(50 or more input/output structures)
Input signaling molecules No. input/output structures
p101_cytoplasm 50
FOXO_cytoplasmINAC 50
GPCRligand_ 50
ComplexGPCRG_sub__alpha_G_sub__beta__
gamma__cytoplasm
50
ComplexRasGDP_cytoplasm 63
ComplexGDPRas_cytoplasm 65
IRligand_ 71
IR_cytoplasm 71
IRS_cytoplasm 71
PKB_cytoplasm 72
PI4,5P2_cytoplasm 120
p85_cytoplasm 123
p110_cytoplasm 123
SOS_cytoplasmINAC 128
GTP_cytoplasm 128
ATP_cytoplasm 130
Grb2_cytoplasm 131
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formations. A similar framework has been proposed before
and successfully implemented for identifying gene knock-
outs in metabolic networks leading to the overproduction of
a particular metabolite (58).
It is important to emphasize that the presence of an
inhibitor molecule leads to the disruption of the correspond-
ing chemical transformation(s) without the need for any
further action. Inhibitor molecules can either be inputs to the
signaling network whose presence can be controlled or they
can be produced through a set of chemical transformations.
This implies that both the set of inputs present and the
underlying chemical transformations in tandem determine
the presence or absence of inhibiting species in the network.
For example, in the context of the small pathway shown in
Fig. 10, recruitment of inputs A, B, and D implies that the
formation of output E is blocked due to the production of
inhibitor molecule C for the transformation D/E. Alterna-
tively, assuming that only the input signaling molecule D is
present in the system enables the production of output E. In
the results described in this section, we assume that all of the
input signaling molecules (Min) are present in the network.
We also postulate that all inhibitor molecules that can be
produced from the set of input signaling molecules (Min) are
present in the system. Therefore, the disruption targets
identiﬁed by the Min-Interference problem are in addition to
those chemical transformations that are not achievable due to
presence of inhibitors. This assumption that all ‘‘reachable’’
inhibitors are present is described mathematically as follows:
+
j2N
Sij rj$ 1; "i 2 IR;
where the set IR is identiﬁed by employing an input/output
feasibility analysis for every inhibitor molecule (6). This
constraint forces a net production of each inhibitor i that
is constitutively available to the system. The set of chemical
transformations that are unreachableor disruptedby thepresence
of inhibitors Ndisihb is found by examining if at least one inhibitor
i for that transformation is a member of set IR.
The conceptual optimization model shown in Fig. 9 is
ﬂeshed-out in full detail as follows. Given the set of input
transformations (Nin), an undesirable output i
 2 Mout, a subset
of desirable outputsMdesout  Mout to be preserved, and the set of
inhibitor molecules (IR), the bilevel optimization problem for
identifying a disruption strategy to prevent an undesirable
outputwhile preserving the desired outputs is posed as follows:
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The objective function 10 for the outer problem minimizes
the ﬂow to the undesirable outcome (i.e., i), whereas the
FIGURE 9 Bilevel optimization structure for suggesting disruption targets.
The inner problem allocates the ﬂuxes through the signaling reactions to
maximize the formation of an undesirable output (i.e., worst-case scenario).
The outer problem then minimizes the ﬂow to the undesirable outcomes by
restricting access (i.e., disrupting) to key transformations available to the
optimization of the inner problem.
FIGURE 10 Set of input signaling molecules present determines the set of
inhibitor molecules that can be formed. Recruitment of input molecules A, B,
and D blocks the production of output E by disruption of the transformation
D/E by the inhibitor molecule C. Alternatively, if input molecule D alone
is present, production of E is preserved. The inhibitor action is indicated by
dotted line.
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objective function for the inner problem 11 maximizes the
ﬂow to the undesirable outcome. This is because the solution
of the inner problem establishes the worst-case scenario for
the system, whereas the outer problem drives this worst-case
ﬂow to the undesirable output to zero by disrupting reaction
steps. Disruption of chemical transformations either by in-
hibitor action or by targeted disruption eliminates reactions
that consume the reactants involved in the disrupted chemical
transformations. Consequently, this leads to the accumulation
of some of these reactant species. This is allowed through
constraint 12, which ensures that no deﬁcit in the mass balance
of any chemical species is present although a surplus or accu-
mulation is allowed. Constraint set 13 ensures that, as dis-
cussed earlier, all inhibitor molecules that can be derived from
the current input signaling molecules are present in the sys-
tem. The inﬂow of input signaling molecules is switched on
by setting them greater than or equal to one (constraint 14).
Constraint 15 disrupts inhibited transformations (by setting
Yj ¼ 0) if the corresponding inhibitor is present. Constraint 16
preserves the desired outputs (Mdesout ) by ensuring that the ﬂow
to these outputs is possible. Constraint 17 forces the reaction
ﬂux corresponding to all disrupted chemical transformations
in the network to zero, and ﬁnally constraint 19 places an
upper limit of K on the number of allowable interferences.
A mathematically valid disruption strategy is identiﬁed if
the value of the objective function reaches zero, implying that
the transmission of the extracellular signal to the undesirable
output is blocked. As in the case of the Min-Input problem,
alternative interference strategies (i.e., multiple optima) are
identiﬁed by implementing the above optimization problem
within an iterative procedure where previously found solu-
tions are excluded at each iteration by employing integer cut
constraints. First, single disruptions are investigated by setting
K equal to one. Multiple disruption strategies are investigated
by successively increasing the value of K by one after all
single disruption strategies are found.
Computational results
The following studies were conducted to test the ability of the
Min-Interference problem to elucidate targeted disruptions:
i. Identify the minimal set of transformations that need to
be disrupted to prevent each output separately (see Fig.
11 a).
ii. Identify the minimal set of transformations that need to be
disrupted to prevent each output separately while preserv-
ing the ﬂow to a set of desirable outputs (see Fig. 11 b).
By iteratively solving the Min-Interference problem once
for each output, we generate the distribution of minimum
interference strategies for disrupting a particular output (see
Fig. 12). Following from our assumptions stated in previous
section, the bar for zero interference corresponds to outputs
that are already inaccessible due to the presence of inhibitor
molecules in the signaling network. Most of the outputs (i.e.,
47) require a minimum of a single disruption to be blocked
and only two outputs require a minimum of two disruptions.
As expected, there exist multiple interference strategies
that can block the formation of an undesirable outcome. We
ﬁnd that the Min-Interference framework is able to suggest
both straightforward strategies involving the disruption of
the ﬁnal transformation(s) leading to the outcome, and
relatively less intuitive strategies that target transformations
far upstream of an undesirable outcome. For example, con-
sider the interference strategies to block the formation of
complex cJun-cFos, a major component of the transcription
factor AP-1, which has been implicated for its role in tumor
growth (59). A straightforward strategy to block the forma-
tion of the complex involves simple disrupting the hetero-
dimeration of transcription factors cJun and cFos (see Fig.
13 a). However, we ﬁnd a number of less intuitive strategies
such as targeting the MEKK1-dependent activation of
protein JNKK1 (see Fig. 13 b).
Overall, a total of 10 distinct disruption strategies (4
single and 6 double) were found to block the formation of
complex cJun-cFos. Whereas the single disruption strate-
gies were found to focus on transformations downstream of
the Ras-Map kinase cascade, the double disruption strate-
gies target transformations within the Ras-Map kinase
cascade. Interestingly, Ras-Map kinase cascades are known
to participate in a diverse array of cellular programs
including growth, proliferation, and survival, and several
drug molecules have been developed to target these cas-
cades as a means to eliminate undesirable outcomes (60).
For example, by employing the drugs U0126 and PD98059,
it is possible to inhibit the phosphorylation of MEK (60).
FIGURE 11 Pictorial representation of the two different problems solved
within the Min-Interference framework. In a, we identify disruption
strategies to prevent an undesirable outcome, whereas in b we identify
disruption strategies to prevent an undesirable outcome while preserving the
formation of desirable outcomes.
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Table 5 lists drug molecules that can carry out the identiﬁed
disruption strategies demonstrating the relevance of iden-
tiﬁed targets.
In the second study, we impose constraints that ensure that
whereas a speciﬁc output is disrupted, a set of desirable ones
is left unaffected. This modiﬁcation attempts to identify
disruptions that are less likely to interfere with necessary
biological processes. The set of desirable outputs here is
listed in Table 6. The identiﬁed distribution of the minimum
required number of disruptions for different outputs, while
preserving the set of desirable outcomes (indicated by
shaded bars in Fig. 12), is almost identical to the previous
case. However, the number of alternative disruption strate-
gies identiﬁed is found to be substantially decreased. For
example, consider the disruption strategy identiﬁed previ-
ously to block the formation of complex cJun-cFos. The total
number of interference strategies decreased from 10 (4
single, 6 double) to 4 (4 single) when the ﬂow to desirable
outputs is preserved. Furthermore, the interference strategies
are found to exclusively target the terminal transformations
located downstream of the Ras-Map kinase cascade rather
than disrupting the initial steps governing the Map kinase
cascade as shown in Fig. 14. In addition to eliminating
complex cJun-cFos, we ﬁnd that the disruption strategies that
target the Map kinase cascades also block the activation of
cPLA2 and the expression of Ets transcription factors, which
play an important role in cell differentiation, cell prolifer-
ation, tissue remodeling, and apoptosis (43) (see Table 5).
These results indicate that when the ﬂow to desirable
outcomes is preserved, the number of alternative interference
strategies decreases and the suggested strategies are found to
predominantly target the terminal transformations of the
signaling pathways.
The hypothesis that by preserving the ﬂow to desirable
outputs the likelihood of side effects is reduced is next tested
by considering two separate examples. First, we explore
blocking the formation of endothelial nitric oxide synthase
(eNOS) an endothelial-cell-speciﬁc isoform of nitric oxide-
producing enzyme. eNOS has been implicated in both angio-
genesis and vasculogenesis, suggesting that the modulation
FIGURE 12 Distribution of the minimum number of interferences
required to disrupt the production of a particular cellular outcome. The
black bars represent the distribution of minimum number of interferences
identiﬁed to block a cellular outcome alone. The shaded bars correspond to
the distribution of minimum number of interferences identiﬁed to block a
cellular outcome while preserving the formation of desirable outcomes.
FIGURE 13 In a, a straightforward strategy to
block the formation of complex cJun-cfos in-
volves disrupting the ﬁnal transformation (R9)
leading to the formation of the complex. A less
intuitive strategy shown in b targets MEKK1-
mediated activation of JNKK1 (R6), which is
located far upstream from the complex.
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of eNOS may be a potent new strategy for the control of
pathological neovascularization (61,62). As illustrated in
Fig. 15 a, one strategy for eliminating eNOS activity is to
disrupt the transport of Ca21 ion from endoplasmic reticu-
lum. However, this also results in loss of cPLA2 activity,
which is implicated in reduced fertility (63). Alternatively,
we ﬁnd that targeting the Ca21-dependent activation of
eNOS within the plasma membrane as shown in Fig. 15 b
preserves cPLA2 activity. Interestingly, this disruption strat-
egy is identical to the action of cavtratin, a cell-permeable
peptide molecule, which by inhibiting eNOS activity, was
shown to exhibit anti-tumor properties (61).
In the previous study, we ﬁnd that the identiﬁed disruption
target can be accomplished by an existing drug molecule.
Next, we describe an example where a disruption strategy is
identiﬁed that to our knowledge is not the target of any
existing drug molecules. Research has implicated Src in the
progression of tumor angiogenesis (64), qualifying Src as an
attractive target for disruption. By disrupting both VEGF and
ﬁbroblast growth factor (FGF) receptor ligand binding,
thalidomide blocks Src activity (see Fig. 16 a) (65).
However, as shown in Fig. 16 a, disrupting both VEGF
and FGF receptor-ligand binding also interferes with the
activation of proteins VRAP, Sck, and HSP27. Experimental
studies have shown that VRAP plays an important role in the
progression of normal angiogenesis (66), and HSP27 is
known to aid in the survival and recovery of cells exposed to
stressful conditions (67). Also, it has been reported that
employing thalidomide as a means of eliminating Src
activity may result in compromised wound healing and
stop the normal reproductive cycle in women, among other
side effects (68). In contrast, we ﬁnd that by imposing as a
restriction the preservation of desired output in Min-Inter-
ference we identify, among others, a previously unexplored
target involving the disruption of both VEGF-VEGFR2 and
FGF-FGFR mediated activation of protein Src (see Fig. 16
b), which preserves VRAP, Sck, and HSP27 activity.
SUMMARY/DISCUSSION
In this work, a computational base was introduced for the
systematic analysis and targeted disruption of signal trans-
duction networks. A stoichiometric formalism was adopted
to model the complex network of interacting molecules in
signaling pathways as a network of chemical transforma-
tions. The cellular stimuli to the signaling pathways were
described as inputs to the signaling network while cellular
responses were abstracted as outputs. The developed frame-
works were benchmarked by applying them to a large-scale
signaling network constructed from nine signaling pathways
known to play an active role in the growth and progression of
prostate cancer. It is important to emphasize that the
introduced frameworks cannot capture dynamic effects in
signal propagation as no kinetic information is included.
Therefore, only connectivity encoded insight can be eluci-
dated implying that further detailed kinetic based analysis
TABLE 5 List of the identiﬁed interference strategies to
block the formation of cJun-cFos along with the list of
available drug molecules reported to be able to block the
targeted transformations
Strategy Type
Disrupted
transformation(s)
Outputs
blocked
Drug
molecule(s) References
1 Single R7 cJun-cFos CNI-1493/JIP-1 (59)
2 Single R8 cJun-cFos Retenoid acid (70)
3 Single R9 cJun-cFos 52R (71)
4 Single R6 cJun-cFos CEP1347 (59)
5 Double R4 cJun-cFos Azathioprine (72)
R3 Ets
cPlA2
6 Double R4 cJun-cFos Azathioprine (72)
R2 Ets U0126/PD98059 (73)
cPLA2
7 Double R1 cJun-cFos RKIP (74)
R4 Ets Azathioprine (72)
cPLA2
8 Double R5 cJun-cFos PN7051 (75)
R1 Ets RKIP (74)
cPLA2
9 Double R2 cJun-cFos U0126/PD98059 (73)
R5 Ets PN7051 (75)
cPLA2
10 Double R5 cJun-cFos PN7051 (75)
R3 Ets Azathioprine (72)
cPlA2
TABLE 6 List of desirable outputs
Desirable outputs
Transcription_
br_cellcycleprogression_Cytosol
VRAP_PlasmaMembrane
Anti-apoptosis_Nucleus Paxillin_PlasmaMembrane
ComplexI_kappa_B
NF_kappa_B_Intracellular
HSP27_PlasmaMembrane
a127_degraded_Intracellular Tumorsuppression_
CSL_Nuclearmembrane Survival_
Ets_Nuclearmembrane Gene_space_transcription_
Cytosol
STAT3_Nuclearmembrane Genetranscription_nucleus
STAT1_Nuclearmembrane S6K_cytoplasm
TCF_Nuclearmembrane GSK3_cytoplasm
PLD_PlasmaMembrane Caspase-9_cytoplasm
PLA_sub_2_endsub_
PlasmaMembrane
BAD_cytoplasm
Src_PlasmaMembrane NOS_cytoplasm
Survivin_PlasmaMembrane ComplexFOXO14-3-3_
cytoplasm
IGFBP1_nucleus Cyclind_nucleus
Rb_LateG_sub_1_endsub_ GADD45_nucleus
a102_degraded_Mitosis scl-1_nucleus
ComplexeNOSCa_super_
21_endsuper_
PlasmaMembrane
ComplexcPLA_sub_
2_endsubCa_super_
21_endsuper_
PlasmaMembrane
The ﬂow to these outputs is preserved while devising interference strategies
for blocking the formation of complex cJun-cFos.
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may be needed to fully recapitulate the underlying input-
output structures and/or interventions.
First, we introduced the Min-Input framework to identify
all cellular stimuli that can elicit the formation of a particular
response. By exhaustively identifying all input/output struc-
tures, Min-Input was able to extract a number of important
topological properties of signaling networks. Speciﬁcally,
we found that the outputs can be classiﬁed into two distinct
sets, highly degenerate or highly speciﬁc depending on
whether they can be elicited by many different input com-
binations or a few dedicated ones. This classiﬁcation has
important implications for guiding the development of thera-
peutic strategies. For example, interfering with highly re-
cruited input molecules (e.g., Sos) is likely to impact many
network functions, whereas affecting inputs with dedicated
participation is more likely to cause only a speciﬁc event.
Similarly, blocking the formation of a highly degenerate
outcome (e.g., cyclinD) is hard to accomplish because it
requires the disruption of multiple steps. Given a set of input
signaling molecules the Min-Interference framework iden-
tiﬁes the minimal set of disruptions needed to eliminate an
undesirable outcome. Computational results indicated that
Min-Interference was able to suggest multiple disruption
strategies that were biologically relevant as several drug mol-
ecules exist to carry out the identiﬁed disruptions. Further-
more, by proactively preserving desirable outputs, disruption
strategies were identiﬁed that appear to be less likely to
involve side effects by contrasting them against the action
and reported side effects of existing drug molecules. Min-
Interference can also be used to examine if a particular com-
bination of drugmolecules is effective when used in combination
and not alone (i.e., exhibit drug synergy). This is particularly
FIGURE 14 Alternative interference strategies identiﬁed
to block the formation of complex cJun-cfos while preserv-
ing the formation of the formation of ETS transcription
factors and cPLA2. The Min-Interference framework ﬁnds
only single interference strategies. As shown in the ﬁgure,
the alternative strategies target transformations R6, R7, R8,
and R9, respectively. Note that all the disruption strategies
target the terminal transformations located downstream of
the MAP kinase cascades.
FIGURE 15 Interference strategies to block eNOS acti-
vation. Disrupting Ca21 transport from the endoplasmic
reticulum eliminates both cPLA2 and eNOS activation as
shown in a. In contrast, disrupting Erk-mediated activation
of eNOS preserves cPLA2 activation as shown in b.
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important for pathologies such as cancer, where multiple path-
ways may be dysfunctional, requiring a combination of sev-
eral drug molecules (44) for effective treatment.
The reconstruction of signaling networks is progressing
with a fast pace (6). Efforts are under way to identify
‘‘signature networks’’ that are highly speciﬁc descriptors of
many diseases (e.g., renal cell carcinoma)(69,70). Whenever
available, the Min-Interference can be used to identify ways
to negate the occurrence of these ‘‘signature networks’’.
Nevertheless, it is important to emphasize that existing sig-
naling reconstructions are inherently incomplete. Therefore,
input-output structure (Min-Input) or disruption results (Min-
Interference) are bound to, for some cases, reﬂect these
missing links. However, results obtained that are inconsistent
with biological knowledge or experiment can be used to
come up with hypotheses for ‘‘ﬁlling in’’ gaps in signaling
reconstructions. Furthermore, the lack of any kinetic infor-
mation in the signaling network description can lead to an
overestimation of the number of viable input-output struc-
tures embedded within a signaling network. However, this
overestimation of the signaling network functionalities
ensures that all identiﬁed disruption strategies will be valid
for the true signaling network. Despite these limitations, this
work represents an important ﬁrst step toward constructing
an integrated computational base for elucidating the input/
output structure and subsequently redesigning signaling
networks.
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